UBS Maintains Neutral on Bath & Body Works, Raises Price Target to $22
Bath & Body Works, Inc. -1.97% Post
Bath & Body Works, Inc. BBWI | 17.94 17.94 | -1.97% 0.00% Post |
UBS analyst Jay Sole maintains Bath & Body Works (NYSE:
BBWI) with a Neutral and raises the price target from $21 to $22.
